A Grand Rapids, Mich., woman who was turned down for a heart transplant for lack of money said Monday that the hospital may reconsider her case now that a fundraising campaign collected more than $28,000 for the anti-rejection drugs she would need.

The committee previously ruled that she was ineligible because she couldn’t afford the drugs, considering the $4,500 annual deductible in her Medicare plan. Martin’s 20 percent drug co-payment would be about $700 a month until she hit the deductible.

In a letter widely seen on social media, a Spectrum Health nurse told Martin that her transplant was denied for now and that the transplant committee recommended she undertake a $10,000 fundraising campaign for the drugs.

As of late Monday, Martin’s GoFundMe campaign had raised nearly $28,300 — including one $10,000 anonymous donation.

Martin, who has congestive heart failure, had been scheduled to undergo surgical implantation of a ventricular assist pump as a “bridge” to her eventual heart transplant. But after the hospital’s rejection letter, the pump became her Plan B survival option.

She expected to live up to eight more years with the pump, compared with 15 to 20 more years if she received a new heart.

However, the pump implantation surgery — scheduled for Monday — was postponed in light of how much money her GoFundMe campaign was raising, according to Martin’s Facebook post.

She wrote: “No surgery today. I requested for my case to be brought to the transplant board again tomorrow. Wish me luck. I have my $10,000 (funding) request fulfilled.”

Martin, whose heart was damaged from chemotherapy for breast cancer in 2005, also expressed gratitude in the Facebook post for all the financial support she received.

“My heart goes out to all of you with the deepest of love and thanks,” she wrote.

Spectrum Health has declined Free Press requests, referring to a general statement about the situation on its website.

It remains unclear whether the hospital system considered contacting the makers of the anti-rejection drugs before issuing the organ transplant denial. Some drugmakers offer deep discounts or even free medication for poor patients in life-threatening situations.

“The fact is that transplants require lifelong care and immunosuppression drugs, and therefore costs are sometimes a regrettable and unavoidable factor in the decision-making process,” Spectrum Health’s statement said.

Representatives of the American Heart Association and Gift of Life Michigan, an organ and tissue donation organization, said they were unaware of any similar situations involving patients who were denied heart transplants for lack of ability to afford post-surgery drugs.